22 Points to Consider for Clinical Trials in Systemic Sclerosis
In this Oxford Academic (Oxford University Press) video, watch Professor Chris Denton talk about his article: ‘Twenty-two points to consider for clinical trials in systemic sclerosis’.
Learn more about scleroderma here: http://bit.ly/learnscleroderma
Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.